BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30815939)

  • 1. Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases.
    Suo N; Guo YE; He B; Gu H; Xie X
    Glia; 2019 Jul; 67(7):1320-1332. PubMed ID: 30815939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C promotes oligodendrocytes generation and remyelination.
    Guo YE; Suo N; Cui X; Yuan Q; Xie X
    Glia; 2018 Jul; 66(7):1302-1316. PubMed ID: 29423921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination.
    Cui X; Guo YE; Fang JH; Shi CJ; Suo N; Zhang R; Xie X
    Acta Pharmacol Sin; 2019 Nov; 40(11):1386-1393. PubMed ID: 30918344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse.
    Sun X; Liu Y; Liu B; Xiao Z; Zhang L
    Exp Neurol; 2012 Oct; 237(2):304-11. PubMed ID: 22836144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
    Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
    Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.
    Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM
    J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
    J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-146a promotes remyelination in a cuprizone model of demyelinating injury.
    Zhang J; Zhang ZG; Lu M; Wang X; Shang X; Elias SB; Chopp M
    Neuroscience; 2017 Apr; 348():252-263. PubMed ID: 28237816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Signaling Regulates Metabolic Function in Oligodendrocyte Precursor Cells and Promotes Efficient Brain Remyelination in the Cuprizone Model.
    Jeffries MA; McLane LE; Khandker L; Mather ML; Evangelou AV; Kantak D; Bourne JN; Macklin WB; Wood TL
    J Neurosci; 2021 Oct; 41(40):8321-8337. PubMed ID: 34417330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.
    Baxi EG; DeBruin J; Jin J; Strasburger HJ; Smith MD; Orthmann-Murphy JL; Schott JT; Fairchild AN; Bergles DE; Calabresi PA
    Glia; 2017 Dec; 65(12):2087-2098. PubMed ID: 28940645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
    Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
    J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
    Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
    J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
    Liu L; Du X; Yang Q; Li M; Ran Q; Liu Q; Yang L; Sun L; Guo Y; Li Y; Chen Y; Zhu X; Li Q
    Phytomedicine; 2022 Nov; 106():154309. PubMed ID: 35994846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis.
    Zhang J; Zhang ZG; Lu M; Zhang Y; Shang X; Chopp M
    Neurobiol Dis; 2019 May; 125():154-162. PubMed ID: 30707940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digestion products of the PH20 hyaluronidase inhibit remyelination.
    Preston M; Gong X; Su W; Matsumoto SG; Banine F; Winkler C; Foster S; Xing R; Struve J; Dean J; Baggenstoss B; Weigel PH; Montine TJ; Back SA; Sherman LS
    Ann Neurol; 2013 Feb; 73(2):266-80. PubMed ID: 23463525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination.
    Yu X; Cheng G; Zhang L; Zhang Y; Wang Q; Zhao M; Zeng L; Hu Y; Feng L
    Sci Rep; 2018 Sep; 8(1):14040. PubMed ID: 30232349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
    Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor learning promotes remyelination via new and surviving oligodendrocytes.
    Bacmeister CM; Barr HJ; McClain CR; Thornton MA; Nettles D; Welle CG; Hughes EG
    Nat Neurosci; 2020 Jul; 23(7):819-831. PubMed ID: 32424285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.